Fluid therapy and outcome: balance is best

Area of Science:

• Critical Care Medicine
• Anesthesiology
• Nephrology

Background:

• Intravenous fluid administration is standard in surgery and critical illness.
• Optimal fluid therapy strategies, including type, dose, and timing, are debated.
• Different fluid types, crystalloids and colloids, have distinct physiological distributions and potential risks.

Purpose of the Study:

• To review current literature on intravenous fluid therapy in critically ill patients.
• To examine the impact of different fluid types (crystalloids vs. colloids) and administration strategies on patient outcomes.
• To identify safety concerns and evidence gaps in fluid management.

Main Methods:

• Review of recent scientific literature concerning intravenous fluid therapy.
• Analysis of studies comparing different types of intravenous fluids (crystalloids and colloids).
• Evaluation of evidence regarding fluid dosage and timing strategies.

Main Results:

• Colloid solutions, especially synthetic starches, are linked to increased morbidity and mortality in critically ill patients.
• Chloride-rich crystalloids (e.g., isotonic saline) may cause metabolic acidosis, hyperchloremia, and acute kidney injury.
• Optimal fluid dosage (restrictive vs. liberal) lacks definitive evidence, remaining controversial.

Conclusions:

• Further high-quality trials are necessary to establish optimal fluid therapy protocols.
• A balanced approach considering fluid type, dose, and timing is currently recommended.
• Careful selection of intravenous fluids is crucial to mitigate potential adverse effects in critically ill and surgical patients.